Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
1.470
-0.020 (-1.34%)
At close: Sep 1, 2026, 4:00 PM EDT
1.470
0.00 (0.00%)
Pre-market: Sep 2, 2026, 4:09 AM EDT

Microbot Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9913419192453
Market Cap Growth
-43.09%608.26%-1.23%-19.16%-55.45%8.85%
Enterprise Value
325515111836
Last Close Price
1.472.001.121.643.017.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.431.735.374.273.263.71
P/TBV Ratio
1.431.735.374.273.263.71

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.030.050.060.05
Net Debt / Equity Ratio
-0.96-1.00-1.52-1.37-1.06-1.03
Net Debt / EBITDA Ratio
3.605.290.470.630.591.31
Net Debt / FCF Ratio
3.715.930.610.720.671.57
Quick Ratio
17.3723.042.262.064.017.90
Current Ratio
18.5623.332.372.094.268.00
Return on Equity (ROE)
-32.91%-32.42%-284.97%-182.19%-121.53%-58.48%
Return on Assets (ROA)
-21.72%-21.04%-101.21%-68.96%-63.11%-32.98%
Return on Capital Employed (ROCE)
-26.60%-18.90%-325.50%-217.00%-177.80%-76.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-16.55%-9.78%-60.34%-55.94%-55.44%-21.22%
FCF Yield
-18.16%-9.76%-46.68%-44.62%-48.98%-17.68%
Buyback Yield / Dilution
-146.72%-192.69%-53.38%-40.49%-2.14%0.14%
SEC Filings: 10-K · 10-Q